141 related articles for article (PubMed ID: 33484485)
21. Low Parathyroid Hormone
Guo W; Zhang H; Zhang Y; Huang H; Liu W; Diao Z
Front Endocrinol (Lausanne); 2022; 13():869330. PubMed ID: 35634511
[TBL] [Abstract][Full Text] [Related]
22. Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study.
Wei Y; Peng LL; Zhao ZL; Li Y; Yu MA
Int J Hyperthermia; 2019; 36(1):1264-1271. PubMed ID: 31818158
[No Abstract] [Full Text] [Related]
23. Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment.
Wei Y; Zhao ZL; Wu J; Cao SL; Peng LL; Li Y; Yu MA
Int J Hyperthermia; 2024; 41(1):2308063. PubMed ID: 38314664
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound-guided microwave ablation for tertiary hyperparathyroidism in patients with renal transplantation.
Yu B; Li J; Lu C; Lu Q; Zhou Y; Luo Y
Int J Hyperthermia; 2023; 40(1):2256497. PubMed ID: 37710400
[TBL] [Abstract][Full Text] [Related]
25. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
26. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
[TBL] [Abstract][Full Text] [Related]
27. [The assessment of cynacalcet (Mimpara) accompanied by alfacalcidol treatment efficacy in haemodialysis patients with different secondary hyperparathyroidism severity recognized by iPTH].
Zwiech R; Dryja P; Łacina D; Nykiel P; Sek-Szczepanowska K; Bratkowska K; Pietrzak B; Chrul S
Wiad Lek; 2011; 64(4):267-73. PubMed ID: 22533150
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA.
Sharma A; Marshall TS; Khan SS; Johns B
Clin Drug Investig; 2014 Feb; 34(2):107-15. PubMed ID: 24214232
[TBL] [Abstract][Full Text] [Related]
29. Initial dosing of paricalcitol based on PTH levels in hemodialysis patients with secondary hyperparathyroidism.
Mitsopoulos E; Zanos S; Ginikopoulou E; Kyriklidou P; Meimaridou D; Sakellariou G
Am J Kidney Dis; 2006 Jul; 48(1):114-21. PubMed ID: 16797393
[TBL] [Abstract][Full Text] [Related]
30. Role of Sonazoid-based contrast-enhanced ultrasonography in the microwave ablation of primary hyperparathyroidism.
Zhou ZB; Xue YE; Yao YW; Zhang XT; Zhang MH; Yang DX; Xie JH
Int J Hyperthermia; 2022; 39(1):155-161. PubMed ID: 35000496
[TBL] [Abstract][Full Text] [Related]
31. [Effect of calcitriol on secondary hyperparathyroidism].
Xu H; Zhang J; Cheng X; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
[TBL] [Abstract][Full Text] [Related]
32. Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success.
Erturk MS; Cekic B; Sarı IK; Pamuk BO
Int J Clin Pract; 2021 Oct; 75(10):e14580. PubMed ID: 34185346
[TBL] [Abstract][Full Text] [Related]
33. [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
Reichel H; Braun J
Dtsch Med Wochenschr; 2011 Jan; 136(4):123-8. PubMed ID: 21181622
[TBL] [Abstract][Full Text] [Related]
34. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study.
Koc H; Hoser H; Akdag Y; Kendir C; Ersoy FF
Int Urol Nephrol; 2019 Jul; 51(7):1261-1270. PubMed ID: 31161518
[TBL] [Abstract][Full Text] [Related]
35. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection.
Zhuo L; Zhang L; Peng LL; Yang Y; Lu HT; Chen DP; Li WG; Yu MA
Int J Hyperthermia; 2019; 36(1):29-35. PubMed ID: 30845851
[TBL] [Abstract][Full Text] [Related]
36. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients.
Gagné ER; Ureña P; Leite-Silva S; Zingraff J; Chevalier A; Sarfati E; Dubost C; Drüeke TB
J Am Soc Nephrol; 1992 Oct; 3(4):1008-17. PubMed ID: 1450363
[TBL] [Abstract][Full Text] [Related]
37. Safety enhancement of improved hydrodissection for microwave ablation in secondary hyperparathyroidism.
Wei Y; Zhao ZL; Niu Y; Wu J; Cao SL; Peng LL; Li Y; Yu MA
Int J Hyperthermia; 2023; 40(1):2243408. PubMed ID: 37544651
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
Qiu X; Gao M; Zhang D; Ji F
Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
[TBL] [Abstract][Full Text] [Related]
39. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.
Zheng CM; Wu CC; Hung CF; Liao MT; Shyu JF; Hsu YH; Lu CL; Wang YH; Zheng JQ; Chang TJ; Lin YF; Lu KC
Nutrients; 2018 Feb; 10(2):. PubMed ID: 29439405
[TBL] [Abstract][Full Text] [Related]
40. Microwave ablation versus parathyroidectomy for the treatment of primary hyperparathyroidism: a cohort study.
Wei Y; Zhao ZL; Cao XJ; Peng LL; Li Y; Wu J; Yu MA
Eur Radiol; 2022 Sep; 32(9):5821-5830. PubMed ID: 35381852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
